Portolani M, Pietrosemoli P, Cermelli C, Mannini-Palenzona A, Grossi M P, Paolini L, Barbanti-Brodano G
Institute of Hygiene, University of Modena, School of Medicine, Italy.
Antiviral Res. 1988 Apr;9(3):205-18. doi: 10.1016/0166-3542(88)90004-6.
Nalidixic acid and oxolinic acid, two antibacterial agents known to inhibit bacterial DNA gyrase, are shown to suppress the replication, as well as the cytopathic effect, of BK virus in Vero cell cultures. The inhibition of virus replication was detectable at day 4 post infection in cultures which had been continuously exposed to drugs at concentrations as low as 0.02 to 0.04 mM of nalidixic acid and 0.2 mM of oxolinic acid. These active concentrations are inferior to plasma levels attained in the course of clinical use of the drugs for antibacterial chemotherapy. Also, under these circumstances, no cytotoxicity occurred. The inhibition of development of cytopathology and of virus-induced cell death was demonstrable in cultures treated for 12 days with the drugs. Under these circumstances of prolonged action, oxolinic acid proved to be slightly cytotoxic in that virus inhibitory doses reduced the viability of normal cells. No alterations in the topological conformation of the viral genome or accumulation of end products of viral DNA replication were detected. However, accumulation of viral DNA form I at 48 h post infection suggests that the drugs act through a mechanism involving DNA topoisomerase.
萘啶酸和恶喹酸是两种已知能抑制细菌DNA促旋酶的抗菌剂,已证实在Vero细胞培养物中它们能抑制BK病毒的复制以及细胞病变效应。在感染后第4天,在持续暴露于低至0.02至0.04 mM萘啶酸和0.2 mM恶喹酸浓度药物的培养物中可检测到病毒复制受到抑制。这些有效浓度低于这些药物在抗菌化疗临床使用过程中所达到的血浆水平。此外,在这些情况下未发生细胞毒性。在用药物处理12天的培养物中可证实细胞病变发展和病毒诱导的细胞死亡受到抑制。在这种延长作用的情况下,恶喹酸被证明有轻微细胞毒性,因为病毒抑制剂量降低了正常细胞的活力。未检测到病毒基因组拓扑构象的改变或病毒DNA复制终产物的积累。然而,感染后48小时病毒DNA I型的积累表明这些药物通过涉及DNA拓扑异构酶的机制起作用。